Starling Oncology, Inc. Inventory
Starling Oncology, Inc. (DFPH) had Inventory of $20.01 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2026-08-06
- 2026-06-30: Inventory, Net $20.01M.
- 2026-03-31: Inventory, Net $24.29M.
- 2025-12-31: Inventory, Net $16.88M.
- 2025-09-30: Inventory, Net $18.88M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $20.01M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $24.29M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $16.88M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $18.88M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $15.79M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $12.31M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $10.04M 10-K · filed 2026-03-12 |
| 2024-09-30 | $10.11M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $11.32M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $11.55M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $13.68M 10-K · filed 2025-03-26 |
| 2023-09-30 | $12.17M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $12.17M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $10.25M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $9.26M 10-K · filed 2024-03-28 |
| 2022-09-30 | $10.02M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $8.58M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $7.77M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $6.44M 10-K · filed 2023-03-16 |
| 2020-12-31 | $4.35M 10-K · filed 2022-03-11 |